Compare TOVX & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TOVX | CHNR |
|---|---|---|
| Founded | 2001 | N/A |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3M | 4.7M |
| IPO Year | 2006 | 1995 |
| Metric | TOVX | CHNR |
|---|---|---|
| Price | $0.22 | $4.23 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.6M | 19.1K |
| Earning Date | 11-12-2025 | 12-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.20 | $3.16 |
| 52 Week High | $2.08 | $8.20 |
| Indicator | TOVX | CHNR |
|---|---|---|
| Relative Strength Index (RSI) | 42.02 | 49.60 |
| Support Level | $0.21 | $3.75 |
| Resistance Level | $0.24 | $4.31 |
| Average True Range (ATR) | 0.03 | 0.29 |
| MACD | 0.00 | 0.12 |
| Stochastic Oscillator | 25.70 | 56.95 |
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
China Natural Resources Inc is engaged in exploration for lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and exploration of attractive opportunities in other sectors. The company has a single operating segment: exploration and mining.